.png)
.png)
Women in Biotech - London
Leading London's Life Science Hubs
The landscape of Life Sciences in London is changing rapidly with new hubs growing across the Capital providing homes to start ups and global players alike, and impressive amounts of investment and property development aimed at the sector. A fantastic panel of women leading the growth of some of these initiatives will discuss progress and their ambitions for life sciences in London as we look towards 2023 and beyond.
Join us for inspirational speakers, engaging discussion and some fantastic networking.
Laura Brightman
Laura studied neuroscience, development and pathology at Cambridge and worked in developmental IPSC models of disease before transitioning to Biotechnology Startups. She attended the Indiebio program in San Franscisco as a co-founder and before joining several other early stage companies. She built their lab spaces particularly in tissue culture and initial testing procedures. During this time several amazing companies in her network failed due to lack of space and resources, something which forced her initial startup to relocate to the US in first place. Through a partnership with Lab Launch, Laura wanted to bring affordable but appropriate space for biotech startups to the UK and Co-Laboratories was born. They are working with local organisations, Universities, other incubators and accelerators to ensure great ideas don't fail just because they don't have a home.
Mairi Dillon
Mairi is Ecosystem Manager for the UK & Ireland at Kadans Science Partner. Kadans Science Partner is the European leader investing in the development of ecosystems and real estate with a dedicated focus on the knowledge intensive sector. They are present on 23 campuses in 7 countries and are backed by AXA IM Alts. Kadans Science Partner and Canary Wharf Group formed a joint venture earlier this year to develop Europe’s largest commercial lab building, with the aim to establish the area as an important hub for UK life sciences. Genomics England have since announced they will be moving their headquarters to Canary Wharf. Mairi has a wealth of experience in early-stage tech fundraising, project management and outward facing relationship building (public and private sector). She began her career in major government sponsored infrastructure projects before moving into the innovation and entrepreneurship landscape. As Head of Operations for a venture capital backed bio-tech start-up, she gained broad business experience bringing a product to market and fundraising both in the UK and abroad. Through her recent roles within the Catapult Network, Smart Specialisation Hub and Innovate UK's Knowledge Transfer Network, Mairi has built a deep understanding of how to link the research, commercial and investment worlds.
Neelam Patel
Neelam is MedCity’s CEO, responsible for leading the team, driving strategy, and forging relationships with key stakeholders and funders. Neelam’s extensive experience spans the private, public and not-for-profit sectors. She has worked with the Association of British Pharmaceutical Industries, the European Innovative Medicines Initiative and collaborated with NHS England, NICE and Public Health England. Neelam regularly supports companies with R&D, advising on the UK regulatory and access landscape. Other roles include being on the advisory board of the Pan-London NIHR Research Design Service, the advisory board of the Innovation Centre in Digital Molecular Technologies at the University of Cambridge, and the board of the Health Research Authority.
Georgina Rizik
Georgina Rizik is a Global Healthcare and Biotechnology Executive with over 25 years of experience across the private, public and non-profit sectors. As the inaugural Executive Director of SC1, Georgina is leading and building the new Life Sciences Innovation District in central London, UK. Georgina brings international commercialization expertise, with a career in Biotechnology and BioPharma that spans leadership roles in global product/portfolio strategy, lifecycle management, business development, launch planning & operations. Most recently, Georgina has been quite engaged in the start-up ecosystem in Canada and globally as an Advisor to Health Tech and Biotech companies. She is Mentor (Associate) at the Creative Destruction Lab for several Health Streams and a Strategy Advisor at VoxCell BioInnovation. Georgina is a globally minded business leader with strategic and cultural agility having worked in Canada, Switzerland, Germany and the UK with deep knowledge of the Canadian, European, US and international health care ecosystems. Experienced in leading teams, these diverse roles have fostered Georgina’s entrepreneurial and collaborative skills, generating global best practices. Georgina holds a Bachelor of Science in Pharmacy from the University of Toronto. In 2009, she earned her executive MBA from the Kellogg-Schulich EMBA Program (Chicago & Toronto). Georgina is a purpose-driven leader who is passionate about transforming the global approach to the commercialization of innovation in order to drive personalized care and health equity.
Members £30.00 +vat
Non-members £40.00 +vat
By registering to this event you accept our Terms & Conditions
VENUE AND EVENT ACCESSIBILITY
We are regularly monitoring changes on government regulations around events. We recommend all attendees take a lateral flow test no more than 24 hours prior to the event. We advise any attendees who are not feeling well or who are displaying Covid-19 symptoms to please not attend.
Alternative or additional precautions like the wearing of masks inside the venue might also be considered and requested.
If you have any questions or problems registering, please contact Sam Care - [email protected]
Bird & Bird LLP
12 New Fetter Lane
London
EC4A 1JP
Transport: The venue is in central London and easily reached by public transport. It is within 10 minutes walk of Chancery Lane, Temple, and Blackfriars stations.
Thank you to our Event Partner:
Thank you to our Women in Biotech series supporter:
Thank you to our event supporter:
